 My name is Dr. Permindurena. I am the lead principal investigator of the Canadian Longitudinal Study on Aging. On behalf of my colleagues across the country, I would like to take this time to thank all of you for participating in the CLSA. Over the past few weeks, we had to make a difficult decision of suspending the face-to-face collection of the CLSA data because of the COVID-19 situation. And we anticipate that this suspension will continue until the end of July 2020. We are closely monitoring the situation. As soon as there is any new development, we will surely be informing you as it relates to the face-to-face data collection. During these times, we have not completely stopped collecting data. We will be contacting you through telephone to collect as much data as possible during these difficult times. We surely hope that you will continue to participate in the CLSA and provide as much data as possible during these difficult circumstances. In addition to the CLSA data collection that we are already engaged in, we are also developing a COVID-19 study to be implemented as part of the CLSA over the next couple of weeks. This study is being done to understand why do some people developing infection and others don't? Why do some people have very severe symptoms and others experience only mild symptoms? All the answers to these questions are key to informing our public health interventions now and in the near future. This COVID-19 study is completely voluntary if we will appreciate that you participate in this study. But it is entirely up to you whether you want to take part in this study or not. This study will be done in two parts. First part will be for the individuals on whom we do have email addresses. So we will be sending you an email with a link embedded within that email that once you click on that link, you will be taken to a web-based questionnaire which will take 20 to 30 minutes of your time to complete at the baseline. Similarly, we have several individuals in the CLSA on whom we do not have any email addresses. Those individuals will be contacted by telephone to complete this 20 to 30 minute interview. After the baseline COVID-19 interviews are finished, we will be contacting you regularly over the next six months to collect a short questionnaire which will not take more than 10 minutes of your time to complete. This repeated questionnaire will collect data on symptoms and consequences if someone develops the infection. We also want to ensure that the data we collect from you is done in a secure fashion. For both our web survey participants as well as telephone participants, if you have any concerns about the legitimacy of the phone call or the email that you receive, please contact us at infoatclsa.elcv.ca or call us by toll-free number at 1-866-989-8303. Again, send us an email at infoatclsa-elcv.ca or call us by toll-free number 1-866-989-8303. We will return your phone call or your message as soon as possible. On behalf of my colleagues, I want to wish all of you good health during these difficult times. I hope you keep yourself safe and your loved ones, and we will be talking to you very shortly. Thank you very much for participating in the CLSA, and I hope you will participate in the CLSA COVID-19 study as well.